Trade Gilead ^GILD

Therapeutics Stocks Q1 Recap: Benchmarking Vertex Pharmaceuticals (NASDAQ:VRTX)

Forum Financial Management LP Sells 9,759 Shares of Gilead Sciences, Inc. $GILD - Zolmax

Forum Financial Management LP Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Janney Montgomery Scott LLC Sells 11,021 Shares of Gilead Sciences, Inc. $GILD

Patton Fund Management Inc. Has $3.01 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Markets Daily

Patton Fund Management Inc. Sells 38,011 Shares of Gilead Sciences, Inc. $GILD

MFA Wealth Services Purchases Shares of 7,677 Gilead Sciences, Inc. $GILD - Markets Daily

Pictet Asset Management Holding SA Buys 218,308 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

How Trodelvy's New First-Line Breast Cancer Role Could Reframe Gilead Sciences' (GILD) Investment Narrative

Medical Stocks To Follow Now - June 27th - Zolmax

Pharmaceutical Stocks To Research - June 27th - Daily Political

Sterling Capital Management LLC Has $9.27 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer

Will Trodelvy's First-Line TNBC Approval Redefine Gilead Sciences' (GILD) Oncology-Led Investment Narrative?

Gilead Sciences (GILD) Wins First Line Trodelvy Approval In The US And Europe

VCI Wealth Management LLC Purchases Shares of 15,683 Gilead Sciences, Inc. $GILD - Daily Political

Gilead (GILD) Wins FDA Approval For Trodelvy In First Line Triple Negative Breast Cancer

Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial Results

144,800 Shares in Gilead Sciences, Inc. $GILD Acquired by Louisiana State Employees Retirement System

Assenagon Asset Management S.A. Boosts Position in Gilead Sciences, Inc. $GILD

Gilead HSV Plan Could Transform Market Outlook

New Drugs Are Replacing Chemo for Aggressive Breast Cancer | Hindustan Times

Gilead Sciences, Inc. $GILD Shares Bought by Fifth Third Wealth Advisors LLC - Stock Observer

The case for prospective MEN1 surveillance in the era of sequential menin inhibitor therapy

5 Set-It-and-Forget-It Stocks to Buy Right Now

Miller Howard Investments Inc. NY Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Stock Observer

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study

US provides Ebola treatment for outbreak in Congo, bringing trials closer

European Commission Grants Marketing Rights For Gilead's Trodelvy In Treating Breast Cancer

3 S&P 500 Stocks with Exciting Potential

Could This FDA Milestone Unlock Gilead's (GILD) Next Big Growth Driver?

True Vision MN LLC Buys Shares of 4,464 Gilead Sciences, Inc. $GILD - Markets Daily

Henrickson Nauta Wealth Advisors Inc. Has $991,000 Position in Gilead Sciences, Inc. $GILD - Daily Political

Prime Medicine, Inc. (PRME) Receives a Hold from Morgan Stanley

Corient Private Wealth LLC Has $73.88 Million Stake in Gilead Sciences, Inc. $GILD

How Investors May Respond To Gilead Sciences (GILD) FDA Review Of Once‑Weekly Oral HIV PrEP

7 Best Longevity and Anti-Aging Stocks to Buy

Larry Mathis Financial Planning LLC Acquires Shares of 4,834 Gilead Sciences, Inc. $GILD - Zolmax

Gilead Sciences, Inc. $GILD Shares Sold by Hsbc Holdings PLC - Zolmax

MidFirst Bank Takes $1.10 Million Position in Gilead Sciences, Inc. $GILD

3 US Pharmaceutical Stocks With Strong Margins And Earnings Growth

SG Trading Solutions LLC Makes New Investment in Gilead Sciences, Inc. $GILD

Pacer Advisors Inc. Sells 208,936 Shares of Gilead Sciences, Inc. $GILD

Invesco Ltd. Raises Stake in Gilead Sciences, Inc. $GILD

Best Pharmaceutical Stocks To Follow Today - June 18th - Daily Political

Man Group plc Decreases Stock Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Moderate Buy" from Brokerages

Gilead Sciences (GILD) Donates Remdesivir to Uganda

State of Wisconsin Investment Board Lowers Holdings in Gilead Sciences, Inc. $GILD

Ibex Wealth Advisors Purchases 54,566 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Stock Position Raised by Siemens Fonds Invest GmbH

Gilead Sciences, Inc. $GILD Holdings Raised by Captrust Financial Advisors

Harvest Investment Advisors LLC Takes Position in Gilead Sciences, Inc. $GILD - Daily Political

&PARTNERS Raises Position in Gilead Sciences, Inc. $GILD

State of Wisconsin Investment Board Sells 24,380 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Siemens Fonds Invest GmbH Buys 8,177 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Insider Sell: Johanna Mercier Sells 3,000 Shares of Gilead Sciences Inc (GILD)

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares

Gilead Sciences (NASDAQ:GILD) CFO Sells $376,200.00 in Stock - Daily Political

Gilead Sciences (NASDAQ:GILD) Earns "Overweight" Rating from Cantor Fitzgerald

GILD Reiterated by Cantor Fitzgerald -- Price Target Maintained

Oddo BHF Asset Management Sas Acquires 35,512 Shares of Gilead Sciences, Inc. $GILD - Zolmax

L2 Asset Management LLC Acquires 10,200 Shares of Gilead Sciences, Inc. $GILD

Rakuten Investment Management Inc. Grows Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Stock Holdings Lifted by Arrowstreet Capital Limited Partnership

Gilead Sciences (NASDAQ:GILD) Receives Overweight Rating from Cantor Fitzgerald - Daily Political

Oddo BHF Asset Management Sas Increases Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Seeks FDA Approval for Weekly HIV Prevention Pill

GILD Receives FDA Acceptance for Yeztugo as HIV Preventative

U.S. FDA Accepts Gilead's Application for Investigational Once-Weekly Oral Yeztugo, Potentially the First Long-Acting Pill for HIV Prevention | Morningstar

Regulatory Milestone Boosts Gilead's Presence in Liver Disease Care

Public Employees Retirement Association of Colorado Purchases 748,517 Shares of Gilead Sciences, Inc. $GILD - Zolmax

TritonPoint Partners LLC Makes New Investment in Gilead Sciences, Inc. $GILD - Markets Daily

TritonPoint Partners LLC Purchases New Holdings in Gilead Sciences, Inc. $GILD - Zolmax

Panagora Asset Management Inc. Reduces Holdings in Gilead Sciences, Inc. $GILD - Zolmax

Panagora Asset Management Inc. Sells 321,348 Shares of Gilead Sciences, Inc. $GILD

Resources Management Corp CT ADV Lowers Stake in Gilead Sciences, Inc. $GILD

Gilead Uganda Remdesivir Donation Puts Global Health And Valuation In Focus

Pharmaceutical Stocks To Follow Today - June 14th - Stock Observer

Gilead Sciences, Inc. $GILD Shares Acquired by Healthcare of Ontario Pension Plan Trust Fund

Epoch Investment Partners Inc. Sells 39,610 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Characterization of liver disease regression in murine models of liver fibrosis and portal hypertension

Gilead Sciences (GILD) Reports Positive Phase 3 IDEAL Results for Livdelzi in PBC